VCEL's Quality Score rose 2 points on Fri, Nov 6, to 21. Its 6-month gain rose to 63%, past 60%.
Follow VCEL's trial news. Pro members can get an alert when Vericel files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 36% from Oct 30 to Nov 6 while the S&P 500 fell 3%.
“The increase in operating expenses was primarily due to increased headcount and related employee expenses, including the MACI sales force expansion”
| Free cash flow up 145% | $10.1M → $24.7M in 3 years |
| Its score | Up:In the top 10 for the first time since at least Oct 2021 |
| Latest filing | 8-K, Nov 5 |
After its last 4 reports it closed +3.3% on average, higher 3 of 4 times.
Chief Legal Officer Sean C. Flynn sold 15,000 shares on Nov 5, under a planned sale. 22 more insider trades this year.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
Exceptionalfor quality, not price, 8 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. VCEL scores 21 today, against a median of 11 over its last 20 recorded sessions.
VCEL is #3 of 281 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score |
Share count against a year before: VCEL +1.4%, IOVA +35%, SRRK +16%, TARS +2.4%.
Expected to report Thu Feb 25, before the open (in 108 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $85.4M, 26% more than a year ago; a profit of $0.27 a share, from $0.10.
“The increase in operating expenses was primarily due to increased headcount and related employee expenses, including the MACI sales force expansion, and an increase in marketing programs.”
VCEL's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Total revenue | $344M to $346M |
Sales grew 17% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 2% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 5, 2026 | +11.1% | +13.8% | not yet |
| Jul 30, 2026 | +4.9% | +2.1% | -2.7% |
| May 7, 2026 | +10.1% | -4.5% | -10.7% |
Sales grew every year from 2018 to 2025, to $276M. It made a profit in three of the eight years.
RSI 78.4, MACD above signal, above both averages. Not scored.
2 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: VCEL is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
VCEL scores 21 today, which Breakaway calls Exceptional. It is #3 of 281 in Biotech by Quality Score, with 8 of 14 chart checks firing. Up 36% from Oct 30 to Nov 6 while the S&P 500 fell 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
VCEL scores 21 today, which Breakaway calls Exceptional (20 or more). That is #3 of 281 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind VCEL's 21.
Expected to report Thu Feb 25, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. VCEL closed higher after 3 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.